Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group ard.bmj.com Rituximab Shows Promise in Scleroderma medpagetoday.com A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease Rituximab (RTX) may favorably affect lung… sciencedirect.com Rituximab for Scleroderma-Associated Pulmonary Arterial Hypertension sclerodermanews.c
